
Opinions
Norman Levine
Teva PharmaceuticalTEVAPAST TOP PICKNov 22, 2017
$13.48
Stock price when the opinion was issued
$31.48
As of Jun 18, 2026. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
(A Top Pick Dec 28/16. Down 61%.) He got out of this 2 months later at about $32, so was down about 10%. Shortly after he bought this, the CEO left for undisclosed reasons, and he took that as a giant warning sign, so he ran away that same day.